Patient population demographics, histologic diagnosis with WHO grade, KPS, PFS, and maximum rCBV values
Patient | Age (yr) | Sex | Pathology | WHO | KPS | PFS (days) | rCBVmax |
---|---|---|---|---|---|---|---|
1 | 26 | M | Astro | 2 | 100 | 298 | 1.1 |
2 | 64 | F | Astro | 4 | 70 | 99 | 9.1 |
3 | 61 | M | Astro | 4 | 80 | 191 | 4.7 |
4 | 43 | F | Astro | 1 | 90 | 668 | 2.1 |
5 | 45 | M | Astro | 2 | 100 | 485 | 2.1 |
6 | 69 | F | Astro | 4 | 60 | 749 | 3.5 |
7 | 79 | M | Astro | 2 | 60 | 210 | 3.0 |
8 | 37 | M | Astro | 2 | 50 | 117 | 4.8 |
9 | 56 | F | Astro | 4 | 100 | 1521 | 1.9 |
10 | 19 | F | Astro | 1 | 90 | 975 | 1.8 |
11 | 46 | M | Oligoastro | 2 | 80 | 1041 | 1.2 |
12 | 56 | F | Oligoastro | 2 | 90 | 1402 | 6.2 |
13 | 43 | M | Astro | 2 | 100 | 428 | 6.1 |
14 | 49 | M | Astro | 4 | 60 | 134 | 4.2 |
15 | 53 | F | Astro | 2 | 90 | 1608 | 2.9 |
16 | 41 | M | Oligoastro | 3 | 100 | 791 | 1.2 |
17 | 19 | M | Astro | 3 | 90 | 1323 | 2.7 |
18 | 20 | M | Astro | 1 | 80 | 392 | 3.8 |
19 | 31 | M | Astro | 1 | 70 | 1831 | 1.2 |
20 | 37 | M | Astro | 3 | 90 | 693 | 6.2 |
21 | 30 | F | Astro | 3 | 90 | 567 | 1.2 |
22 | 16 | F | Oligodendro | 3 | 70 | 1302 | 2.2 |
23 | 40 | M | Oligodendro | 2 | 80 | 546 | 1.1 |
24 | 37 | F | Oligodendro | 2 | 100 | 1540 | 5.6 |
25 | 43 | F | Oligodendro | 2 | 100 | 380 | 4.1 |
26 | 68 | F | Astro | 3 | 80 | 57 | 7.8 |
27 | 61 | M | Astro | 4 | 50 | 85 | 11 |
28 | 81 | M | Astro | 4 | 70 | 28 | 8.0 |
29 | 38 | F | Astro | 2 | 80 | 546 | 1.0 |
30 | 53 | M | Astro | 4 | 100 | 76 | 4.4 |
31 | 51 | M | Astro | 2 | 90 | 386 | 1.1 |
32 | 41 | M | Astro | 3 | 100 | 334 | 1.5 |
33 | 41 | F | Astro | 2 | 80 | 911 | 1.3 |
34 | 46 | M | Astro | 2 | 90 | 699 | 2.4 |
Note:—Astro indicates astrocytoma; oligoastro, oligoastrocytoma; oligodendro, oligodendroglioma; KPS, Kornofsky performance score; PFS, progression-free survival; rCBV, relative cerebral blood volume.